Qinghua Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qinghua Tang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Baorong He
Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Beilin District, Xi'an, Shanxi Province, 710000, China
1 shared publication - Chao Qiang Jiang
Guangzhou Twelfth People’s Hospital, Guangzhou, China
1 shared publication - Dingjun Hao
Department of Spine Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China
1 shared publication - Heng Li
Key Laboratory of Automobile Materials (Jilin University), Ministry of Education, and College of Materials Science and Engineering, Jilin University, Changchun, China
1 shared publication - Jiancheng Yang
Department of Osteoporosis, Honghui Hospital, Xi’an Jiaotong University, Xi’an 710054, China
1 shared publication Jinpeng Du
Department of Spine Surgery, Honghui Hospital, Xi’an Jiao Tong University, Xi’an, China
1 shared publication
Latest Publications
- 9 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (3) , e70379
Prussian blue nanoparticles prevent RANKL ‐induced osteoclastogenesis by scavenging ROS and inactivating NF ‐ κB / MAPK signaling pathways
The accumulation of intracellular reactive oxygen species (ROS) is widely recognized to stimulate the development of osteoclasts, a crucial factor in the onset of osteoporosis. The ROS scavenging capability of Prussian blue nanoparticles (PBNPs) is exceptional, and they possess excellent biocompatibility. However, the effects of PBNPs on osteoporosis remain unknown. Present study aimed to investigate whether PBNPs could inhibit osteoclast differentiation and prevent ovariectomy (OVX)‐induced bone loss by suppressing ROS. In vitro experiments demonstrated that PBNPs attenuated osteoclastogenesis and downregulated the expression of osteoclast‐related genes. Mechanistically, PBNPs reduce cellular ROS by blocking RANKL‐induced ROS generation and increasing the expression of ROS scavenging enzymes, which in turn block the NF‐κB, ERK, JNK, and p38 pathways, thereby reducing NFATc1 signaling. According to in vivo experimental results, OVX caused a significant rise in ROS in the bone marrow, an increase in osteoclastic number on the bone surface, and substantial bone loss; however, PBNPs significantly reduced ROS and successfully protected OVX‐induced bone damages. In conclusion, this study showed for the first time that PBNPs prevented OVX‐induced bone loss and attenuate osteoclastogenesis, indicating that PBNPs may be a viable alternative therapy for the management of osteoclast‐associated bone disorders.
- 9 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (3) , e70379
Prussian blue nanoparticles prevent RANKL ‐induced osteoclastogenesis by scavenging ROS and inactivating NF ‐ κB / MAPK signaling pathways
The accumulation of intracellular reactive oxygen species (ROS) is widely recognized to stimulate the development of osteoclasts, a crucial factor in the onset of osteoporosis. The ROS scavenging capability of Prussian blue nanoparticles (PBNPs) is exceptional, and they possess excellent biocompatibility. However, the effects of PBNPs on osteoporosis remain unknown. Present study aimed to investigate whether PBNPs could inhibit osteoclast differentiation and prevent ovariectomy (OVX)‐induced bone loss by suppressing ROS. In vitro experiments demonstrated that PBNPs attenuated osteoclastogenesis and downregulated the expression of osteoclast‐related genes. Mechanistically, PBNPs reduce cellular ROS by blocking RANKL‐induced ROS generation and increasing the expression of ROS scavenging enzymes, which in turn block the NF‐κB, ERK, JNK, and p38 pathways, thereby reducing NFATc1 signaling. According to in vivo experimental results, OVX caused a significant rise in ROS in the bone marrow, an increase in osteoclastic number on the bone surface, and substantial bone loss; however, PBNPs significantly reduced ROS and successfully protected OVX‐induced bone damages. In conclusion, this study showed for the first time that PBNPs prevented OVX‐induced bone loss and attenuate osteoclastogenesis, indicating that PBNPs may be a viable alternative therapy for the management of osteoclast‐associated bone disorders.
- 2 December 2020
- Published by Springer Nature in Spinal Cord
- Vol. 59 (7) , 804-813
Epidemiological characteristics of traumatic spinal cord injury in Xi’an, China
Study design A hospital-based retrospective epidemiological study. Objective To describe the demographic and epidemiological characteristics of patients with traumatic spinal cord injury (TSCI) in Xi’an to help health-related institutions formulate corresponding measures. Setting People with TSCI, all spine centres and orthopaedic centres in Xi’an, China. Methods We retrospectively reviewed the medical records of the all spine centers or orthopedic centers in Xi’an according to the International Classification of Disease Version 10 (ICD-10) and diagnostic code of TSCI. Variables included gender, age, medical insurance, etiology, occupation, level of injury, and severity of injury, multiple injury, complication, treatment, and so on. Results The study included the medical records of 1730 patients with TSCI from 2014 to 2018. The estimated annual incidence rate increased from 39.0 cases (95% CI, 34.7–43.3 cases) per 1 million persons in 2014 to 43.2 cases (95% CI, 39.0–47.5 cases) per 1 million persons in 2018. The leading cause of TSCI was high falls (35.5%, 614 cases). The most common injury site was the cervical spinal cord, accounting for 55.7% (963 cases). The degree of injury severity with the highest proportion was incomplete tetraplegia (47.2%, 816 cases). In addition, 71.4% (1236 cases) of TSCI cases had spinal fracture or dislocation. Conclusions There are specific epidemiological characteristics of TSCI patients in Xi’an, and preventive measures are suggested to be based on the characteristics of the different types of patients with TSCI and focused on high-risk groups.
- 2 December 2020
- Published by Springer Nature in Spinal Cord
- Vol. 59 (7) , 804-813
Epidemiological characteristics of traumatic spinal cord injury in Xi’an, China
Study design A hospital-based retrospective epidemiological study. Objective To describe the demographic and epidemiological characteristics of patients with traumatic spinal cord injury (TSCI) in Xi’an to help health-related institutions formulate corresponding measures. Setting People with TSCI, all spine centres and orthopaedic centres in Xi’an, China. Methods We retrospectively reviewed the medical records of the all spine centers or orthopedic centers in Xi’an according to the International Classification of Disease Version 10 (ICD-10) and diagnostic code of TSCI. Variables included gender, age, medical insurance, etiology, occupation, level of injury, and severity of injury, multiple injury, complication, treatment, and so on. Results The study included the medical records of 1730 patients with TSCI from 2014 to 2018. The estimated annual incidence rate increased from 39.0 cases (95% CI, 34.7–43.3 cases) per 1 million persons in 2014 to 43.2 cases (95% CI, 39.0–47.5 cases) per 1 million persons in 2018. The leading cause of TSCI was high falls (35.5%, 614 cases). The most common injury site was the cervical spinal cord, accounting for 55.7% (963 cases). The degree of injury severity with the highest proportion was incomplete tetraplegia (47.2%, 816 cases). In addition, 71.4% (1236 cases) of TSCI cases had spinal fracture or dislocation. Conclusions There are specific epidemiological characteristics of TSCI patients in Xi’an, and preventive measures are suggested to be based on the characteristics of the different types of patients with TSCI and focused on high-risk groups.